JP2009530393A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530393A5
JP2009530393A5 JP2009501562A JP2009501562A JP2009530393A5 JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5 JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5
Authority
JP
Japan
Prior art keywords
monocyclic
compound
alkyl
bicyclic
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009501562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/007146 external-priority patent/WO2007111954A2/en
Publication of JP2009530393A publication Critical patent/JP2009530393A/ja
Publication of JP2009530393A5 publication Critical patent/JP2009530393A5/ja
Withdrawn legal-status Critical Current

Links

JP2009501562A 2006-03-23 2007-03-22 プリン化合物およびその使用方法 Withdrawn JP2009530393A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78501406P 2006-03-23 2006-03-23
US78509306P 2006-03-23 2006-03-23
US78509406P 2006-03-23 2006-03-23
US78509206P 2006-03-23 2006-03-23
PCT/US2007/007146 WO2007111954A2 (en) 2006-03-23 2007-03-22 Purine compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2009530393A JP2009530393A (ja) 2009-08-27
JP2009530393A5 true JP2009530393A5 (enExample) 2010-05-06

Family

ID=38541654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009501562A Withdrawn JP2009530393A (ja) 2006-03-23 2007-03-22 プリン化合物およびその使用方法

Country Status (10)

Country Link
US (1) US20070238694A1 (enExample)
EP (1) EP1996020A4 (enExample)
JP (1) JP2009530393A (enExample)
KR (1) KR20080110816A (enExample)
AU (1) AU2007229463A1 (enExample)
BR (1) BRPI0709124A2 (enExample)
CA (1) CA2643503A1 (enExample)
IL (1) IL193693A0 (enExample)
MX (1) MX2008012185A (enExample)
WO (1) WO2007111954A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1758596E (pt) 2004-05-26 2010-06-23 Inotek Pharmaceuticals Corp Derivados de purina como agonistas do receptor de adenosina a1 e processos para a sua utilização
NZ554506A (en) * 2004-09-20 2011-01-28 Inotek Pharmaceuticals Corp Purine derivatives and methods of use thereof
AU2006320578B2 (en) * 2005-11-30 2013-01-31 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN102665730A (zh) * 2009-10-26 2012-09-12 伊诺泰克制药公司 眼用制剂及其制造方法
BR112012017106A2 (pt) 2010-01-11 2018-05-29 Inotek Pharmaceuticals Corp combinação, kit e método de redução de pressão intraocular.
JP2013523739A (ja) * 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション N6−シクロペンチルアデノシン(cpa)、cpa誘導体またはそれらのプロドラッグを用いてヒトにおける眼内圧を低下させる方法
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
NZ627778A (en) * 2012-01-26 2017-01-27 Inotek Pharmaceuticals Corp Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
AU2014239222A1 (en) 2013-03-15 2015-10-01 Inotek Pharmaceuticals Corporation Ophthalmic formulations
CN105188713A (zh) * 2013-03-15 2015-12-23 伊诺泰克制药公司 提供眼部神经保护的方法
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875751B2 (en) * 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
CA2484921A1 (en) * 2002-05-06 2003-11-13 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis c virus infection
PT1758596E (pt) * 2004-05-26 2010-06-23 Inotek Pharmaceuticals Corp Derivados de purina como agonistas do receptor de adenosina a1 e processos para a sua utilização
NZ554506A (en) * 2004-09-20 2011-01-28 Inotek Pharmaceuticals Corp Purine derivatives and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2009530393A5 (enExample)
JP2009504763A5 (enExample)
JP2005518350A5 (enExample)
JP2013509411A5 (enExample)
JP2013508279A5 (enExample)
JP2003506354A5 (enExample)
CN111836814A (zh) 稠环化合物、其制备方法及用途
JPWO2019195124A5 (enExample)
JP2009513658A5 (enExample)
WO2012138894A4 (en) Hsp90 inhibitors
JP2008545793A5 (enExample)
JP2005501110A5 (enExample)
JP2007501779A5 (enExample)
CA2303815A1 (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
RU2009144538A (ru) Новые циклические пептидные соединения
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2007515476A5 (enExample)
RU2014109441A (ru) Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами
JP2008510758A5 (enExample)
JP2020524178A5 (enExample)
JP2005513017A5 (enExample)
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
JP2007503420A5 (enExample)
JP6017766B2 (ja) 新規な金属サレン錯体化合物の抗がん剤